Educator Programs & Events

The Yale Program in Addiction Medicine is pleased to welcome E. Jennifer Edelman, MD, MHS, as guest speaker for Addiction Medicine Grand Rounds on April 28th, 2026.

This event will be held in a virtual format.

Title: Integrating Addiction Treatment in HIV Clinical Settings: A Focus on SMARTTT Findings

Learning Objectives:

1. Recognize gaps in tobacco use disorder treatment among individuals with HIV
2. Identify evidence-based approaches to address tobacco use disorder treatment in HIV clinical settings
3. Describe innovative strategies to address tobacco use disorder in HIV clinical settings

Addiction Medicine Rounds are CME accredited. Each session will be assigned 1 AMA PRA Category 1 CreditsTM

Overview

This will be a current and authoritative one day course on systemic lupus erythematosus, with comprehensive sessions on pathogenesis, diagnosis and treatment. Our distinguished faculty will interact with participants through didactic lectures and interactive panel discussions.

Target Audience

Specialties - Dermatology, Emergency Medicine, Family Practice, Hospitalist, Infectious Diseases, Internal Medicine, Multiple Specialties, Nurse Practitioner, Pediatrics, Rheumatology

Audience - Physician, Nurse, Advanced Practice Provider, Fellow, Student

Objectives

At the end of this symposium, participants will be able to:

• Apply evidence-based diagnostic criteria and assessment tools, in collaboration with interprofessional care team members, to accurately diagnose patients with systemic lupus erythematosus (SLE).
• Implement guideline-concordant, team-based treatment strategies to optimize the management of patients with SLE across disease stages.
• Evaluate and integrate emerging therapies for SLE into shared, interprofessional clinical decision-making, aligned with the roles and responsibilities of the care team.

Please see our conference website for registration details.

Target Audience

Specialties - Pulmonology

Professions -Physician, Nurse, Advanced Practice Provider, Fellow, Student

Overview

Despite therapeutic advances, the prognosis of pulmonary hypertension remains poor which likely reflects in part delayed detection of the disease and scarcity of disease modifying therapies currently available. The former is important especially amongst health care providers given the myriad of conditions that can result in pulmonary hypertension, including chronic liver disease, left heart disease, and connective tissue disease. Early recognition of the pulmonary hypertension and recognizing the indication & limitations of current pulmonary artery hypertension-specific therapies are important to allows for prompt and appropriate treatment strategies. Knowledge on the peri-operative, acute, and chronic management strategies of patients with pulmonary hypertension are important for health care providers to understand the complexity of managing patients with pulmonary hypertension.

Objectives

• Explore novel and established diagnostic and management approaches in patients with pulmonary hypertension
• Identify the different treatment approaches in acute RV failure.
• Discuss the different diagnostic and management approach for patients with PH associated with chronic obstructive pulmonary disease.

Please see our conference website for registration details.

The Yale Multiple Sclerosis Symposium, taking place on May 8, 2026, at the New Haven Lawn Club in New Haven, Connecticut, will provide clinicians with an in-depth update on the rapidly evolving field of Multiple Sclerosis (MS). MS remains one of the most common neurological disorders causing disability in young adults, with more than one million individuals currently affected in the United States. Advances in disease phenotyping, diagnostic imaging, and therapeutic strategies continue to reshape the management of MS, creating an ongoing need for clinicians to stay current with emerging evidence and evolving standards of care. This symposium will review recent scientific developments, highlight best practices in clinical management, and equip providers with practical strategies to improve outcomes and enhance the quality of care for individuals living with MS.

Please visit our conference website at: https://yale.cloud-cme.com/ms2026 for full course details including registration.

The Yale Program in Addiction Medicine is pleased to welcome Wajahat Mehal, MD, PhD, DPhil, as guest speaker for Addiction Medicine Grand Rounds on May 12th, 2026.

This event will be held in a virtual format.

Title: Applications of GLP-1s in Addressing Blood Alcohol Level in the Context of Liver Disease

Learning Objectives:

Forthcoming

Addiction Medicine Rounds are CME accredited. Each session will be assigned 1 AMA PRA Category 1 CreditsTM

This session will establish context as to why it is necessary to differentiate jobs from careers, propose a rubric to classify and triage job versus career needs, and offer specific, behaviorally-focused action plans to make more time available for career development. Topics for which action plans are offered include calendar management, explicit prioritization of important but non-urgent tasks, more effective email use, and mitigating electronic distractors. The need to say no to particular asks and opportunities will also be covered. While applicable to faculty at all stages, the session is likely most impactful for those in early and mid-careers.

Session Type: Repeat Offering (Session content similar to 2024-25 session. Best suited for those new to the material or who may benefit from a refresher.)

Associated Clinician Educator Milestones:

• UP 1: Universal Pillar 1: Reflective practice and commitment to personal growth
• UP 2: Universal Pillar 2: Well-being of learners and colleagues
• UP 4: Universal Pillar 4: Commitment to professional responsibilities

This webinar brings together leaders from academic medical centers for a candid conversation on how artificial intelligence (AI) is being used to support student feedback, build AI literacy across undergraduate medical education, graduate medical education, and continuing medical education, and strengthen clinical reasoning skills.

This moderated roundtable will explore real‑world approaches—including using AI as a thought partner rather than an answer engine—along with lessons learned, guardrails for responsible use, and emerging questions institutions are navigating together. The discussion will feature distinguished guests from Mt. Sinai, Stanford, UTHealth Houston, and University of Washington.

How to carve our teaching time in the middle of a busy clinic setting? Learn these effective on-the-fly teaching strategies to help you and your learners both feel productive.

Session Type: Repeat Offering (Session content similar to 2024-25 session. Best suited for those new to the material or who may benefit from a refresher.)

Associated ACGME Clinician Educator Milestones:

• ETP 1: Educational Theory and Practice 1: Teaching and Facilitated Learning
• ETP 3: Educational Theory and Practice 3: Learner Assessment

The Yale Program in Addiction Medicine is pleased to welcome Susan Calcaterra, MD, MPH, MS, Melissa Weimer, DO, MCR, and Megan Buresh, MD, as guest speakers for Addiction Medicine Grand Rounds on May 26th, 2026.

This event will be held in a virtual format.

Title: Leveraging the 72-Hour Rule Change to Support Transition From Hospital to Opioid Treatment Program

Learning Objectives:

Forthcoming

Addiction Medicine Rounds are CME accredited. Each session will be assigned 1 AMA PRA Category 1 CreditsTM

Target Audience

Specialties - Gastroenterology, Hepatology, Primary Care

Professions - Non-Physician, Nurse, Nurse Practitioner, PA, Physician, Student

Overview

The Yale Digestive Disease Week Review, hosted by faculty from Yale School of Medicine, Department of Internal Medicine, Section of Digestive Diseases, is an annual continuing medical education program designed to deliver timely, clinically relevant updates from the national Digestive Disease Week (DDW) meeting. Each year, Yale faculty members attend DDW, identify the most impactful research, guideline updates, and therapeutic innovations, and then present these key learnings to regional gastroenterologists, hepatologists, primary-care clinicians, advanced practice providers, and other allied health professionals. This program ensures that clinicians who are unable to attend DDW receive a comprehensive and curated review of the newest advances in gastroenterology, hepatology, endoscopy, microbiome science, and digestive-disease management. The sessions emphasize translation of emerging evidence into daily clinical practice, promote interdisciplinary discussion, and support improved patient outcomes across the continuum of digestive health care.

Objectives

1. Summarize the most important scientific updates, guideline changes, and emerging clinical evidence presented at the national Digestive Disease Week meeting.
2. Incorporate new diagnostic and therapeutic recommendations into clinical decision-making for common and complex GI and hepatology conditions.
3. Evaluate the implications of new endoscopic technologies, innovations, and procedural data for patient management and procedural planning.
4. Apply evidence-based strategies discussed at DDW to optimize patient outcomes in areas such as colorectal cancer screening, liver disease, IBD management, microbiome-related disorders, and gastrointestinal oncology.
5. Identify opportunities to reduce variation in clinical practice by aligning care with current national standards and expert-reviewed data.
6. Strengthen multidisciplinary collaboration by translating new research findings into coordinated care approaches across gastroenterology, hepatology, primary care, nutrition, and surgical specialties.
7. Enhance interprofessional collaboration by integrating DDW evidence and best practices into team-based approaches involving physicians, nurses, advanced practice providers, and other allied health professionals to improve communication, coordination, and overall quality of digestive health care.

Please see our conference website for registration details.

Hosted by the Center for Medical Education, this conference is open to the community of educators from the Yale health profession schools. All Yale students, faculty, fellows, residents, staff, and alumni are welcome to attend. Continuing medical education (CME) credit will be available. Conference attendance is free.

The Yale Program in Addiction Medicine is pleased to welcome Jade Boyd, PhD, as guest speaker for Addiction Medicine Grand Rounds on June 9, 2026.

This event will be held in a virtual format.

Title: Sex Work and Substance Use

Learning Objectives:

Forthcoming

Addiction Medicine Rounds are CME accredited. Each session will be assigned 1 AMA PRA Category 1 CreditsTM

Tuesday, June 9, 2026 | 5:00 PM - 6:00 PM

The goal of this virtual, interactive lecture series is to update care providers on the latest advances in fetal diagnostic criteria and optimal management to enhance their skills in prenatal diagnosis, counseling and treatment. Hosted by the Fetal Care Center at Yale New Haven Children's Hospital, this series provides a forum to delineate fetal diagnoses, therapies available, and the impact they can have on pregnancy management and maternal/fetal outcomes.

Objectives

1. Identify maternal and fetal indications for various fetal interventions and associated maternal-fetal outcomes
2. Discuss prenatal counseling, obstetrical management, fetal therapy options, fetal surveillance and delivery planning for fetuses with select fetal anomalies
3. Discuss ongoing research endeavors related to maternal-fetal health and childhood outcomes

Registration:

Please visit our conference website at https://yale.cloud-cme.com/fetalcareseries2026 for full course details including registration.

Upcoming topics:
Management of Fetal Lung Lesions Before and After Birth - Wednesday, September 9, 2026

Prenatal Genetic Diagnostic Testing + Case Examples - Tuesday, October 6, 2026

Ex-Utero Intro-partum (EXIT) Procedure for Fetal Airway Obstruction - Monday, December 7, 2026

Location: New Haven Lawn Club

Cardiogenic shock is a high risk clinical syndrome that requires timely recognition and structured decision making to guide escalation of therapy. This activity will explore contemporary strategies for the assessment and management of cariogenic hock with an emphasis on mechanical circulatory support.

Registration is complimentary; however, we require you to register to account for seating and meals. Please see our conference website for registration details.

The Yale Program in Addiction Medicine is pleased to welcome Tania Strout, PhD, as guest speaker for Addiction Medicine Grand Rounds on June 23, 2026.

This event will be held in a virtual format.

Title: Sex Work and Substance Use

Learning Objectives:

Forthcoming

Addiction Medicine Rounds are CME accredited. Each session will be assigned 1 AMA PRA Category 1 CreditsTM

Yale’s Review of Advances in Oncology: Highlights from the ASCO® Annual Meeting is set to host a live symposium on Friday, June 26, 2026. This event aims to deliver the latest advancements and pivotal insights from the 2026 American Society of Clinical Oncology (ASCO®) Annual Meeting. Developed by our esteemed faculty, this program is tailored to meet the educational requirements of healthcare professionals. The agenda is created to augment participants’ understanding and confidence in current and emerging treatment modalities, ongoing clinical trials, and best practices in cancer care. Attendees will gain access to essential information without the need to sift through multiple days of content. Engaging lectures and case-based discussions will facilitate the review of new findings alongside leading experts, enabling the integration of these updates into clinical settings.